WEDBUSH SECURITIES INC - CATABASIS PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
WEDBUSH SECURITIES INC ownership history of CATABASIS PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2017$534,000
+3714.3%
251,802
+2368.6%
0.07%
+3350.0%
Q2 2017$14,00010,2000.00%
Other shareholders
CATABASIS PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
SV Health Investors, LLC 2,857,667$4,572,0005.05%
Clarus Ventures, LLC 2,752,488$4,404,0003.28%
SPHERA FUNDS MANAGEMENT LTD. 388,030$621,0000.12%
Rhenman & Partners Asset Management AB 310,756$497,0000.08%
BOSTON FAMILY OFFICE LLC 24,467$39,0000.01%
OPPENHEIMER & CO INC 90,000$144,0000.00%
Alyeska Investment Group, L.P. 221,281$354,0000.00%
A.R.T. Advisors, LLC 46,747$74,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 101,347$162,0000.00%
Acrospire Investment Management LLC 680$1,0000.00%
View complete list of CATABASIS PHARMACEUTICALS IN shareholders